Vitruvian Partners LLP
13F Reported Value
ⓘ$201.0M
Holdings
8
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Vitruvian Partners LLP disclosed 8 positions worth $201.0M in its Form 13F-HR for Q2 2026, led by $MQ (Marqeta, Inc.) at 55.4% of the equity portfolio, followed by $HNGE and $XMTR. During the quarter the fund opened 1 new position and exited 0 — including a new stake in $WSE. The portfolio is most concentrated in Technology (85.9% of disclosed assets). All figures are sourced directly from Vitruvian Partners LLP’s Form 13F-HR filing with the SEC under CIK 1692590.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 54.9#1,293
Quality
$111.3M6,853,183 sh - 74.9#105
Quality
$42.0M506,599 sh - 48.3#1,732
Quality
$17.5M181,169 sh - 63.2
Quality
$11.9M350,044 sh - —
Quality
$7.3M210,209 sh - 14.3
Quality
$6.2M5,043,356 sh - —
Quality
$3.4M281,277 sh - 28.1
Quality
$1.3M278,865 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Marqeta, Inc.$MQ | 54.9#1,293 | $111.3M | 6,853,183 |
 Hinge Health, Inc.$HNGE | 74.9#105 | $42.0M | 506,599 |
 Xometry, Inc.$XMTR | 48.3#1,732 | $17.5M | 181,169 |
 CarGurus, Inc.$CARG | 63.2 | $11.9M | 350,044 |
 Global-E Online Ltd.$GLBE | — | $7.3M | 210,209 |
 MAXCYTE, INC.$MXCT | 14.3 | $6.2M | 5,043,356 |
 Wise Group plc$WSE | — | $3.4M | 281,277 |
 RxSight, Inc.$RXST | 28.1 | $1.3M | 278,865 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Vitruvian Partners LLP's 8 positions.
Showing top 8 of 8 holdings.
Sector Allocation
Technology
$172.6M
Industrials
$20.8M
Healthcare
$7.5M
Full Holdings — Vitruvian Partners LLP (Q2 2026)
All 8 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $MQ | Marqeta, Inc. | $111.3M | 55.4% | +0% | 54.9 |
| 2 | $HNGE | Hinge Health, Inc. | $42.0M | 20.9% | -59% | 74.9 |
| 3 | $XMTR | Xometry, Inc. | $17.5M | 8.7% | -6% | 48.3 |
| 4 | $CARG | CarGurus, Inc. | $11.9M | 5.9% | -26% | 63.2 |
| 5 | $GLBE | Global-E Online Ltd. | $7.3M | 3.6% | +0% | — |
| 6 | $MXCT | MAXCYTE, INC. | $6.2M | 3.1% | +0% | 14.3 |
| 7 | $WSE | Wise Group plc | $3.4M | 1.7% | NEW | — |
| 8 | $RXST | RxSight, Inc. | $1.3M | 0.7% | +0% | 28.1 |
New Positions (1)
$WSE Wise Group plc$3.4MBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Vitruvian Partners LLP including:
Track Vitruvian Partners LLP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Vitruvian Partners LLP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Vitruvian Partners LLP
13F Pro is an AI hedge fund tracker and stock research platform. For Vitruvian Partners LLP (SEC CIK: 1692590), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Vitruvian Partners LLP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.